NEXGEL, INC. Net Income (Loss) Attributable to Noncontrolling Interest
NEXGEL, INC. (NXGL) reported Net Income (Loss) Attributable to Noncontrolling Interest of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-17
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $29.00K, a 16.00% increase year-over-year.
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $56.00K, a 64.71% increase year-over-year.
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $42.00K, a 61.54% increase year-over-year.
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $6.00K.
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $107.00K.
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$182.00K.
- NEXGEL, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$31.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-17 | $85.00K 10-Q · filed 2026-08-17 | $127.00K derived: sum of 3 quarters · filed 2026-08-17 | $133.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-14 | $98.00K derived: sum of 2 quarters · filed 2026-05-14 | $104.00K derived: sum of 3 quarters · filed 2026-05-14 | $129.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $48.00K derived: sum of 2 quarters · filed 2026-03-31 | $73.00K derived: sum of 3 quarters · filed 2026-08-17 | $107.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-12 | $31.00K derived: sum of 2 quarters · filed 2026-08-17 | $65.00K 10-Q · filed 2025-11-12 | $91.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $25.00K 10-Q · filed 2026-08-17 | $59.00K 10-Q · filed 2026-08-17 | $85.00K derived: sum of 3 quarters · filed 2026-08-17 | $24.00K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-14 | $60.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.00K derived: sum of 3 quarters · filed 2026-05-14 | -$95.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$35.00K derived: sum of 2 quarters · filed 2026-03-31 | -$129.00K derived: sum of 3 quarters · filed 2026-03-31 | -$182.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$61.00K 10-Q · filed 2025-11-12 | -$155.00K derived: sum of 2 quarters · filed 2025-11-12 | -$208.00K 10-Q · filed 2025-11-12 | -$296.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$94.00K 10-Q · filed 2025-08-12 | -$146.00K 10-Q · filed 2025-08-12 | -$235.00K derived: sum of 3 quarters · filed 2025-08-12 | -$237.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$52.00K 10-Q · filed 2025-05-13 | -$141.00K derived: sum of 2 quarters · filed 2025-05-13 | -$143.00K derived: sum of 3 quarters · filed 2025-05-13 | -$90.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$91.00K derived: sum of 2 quarters · filed 2025-03-27 | -$38.00K derived: sum of 3 quarters · filed 2025-03-27 | -$31.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$2.00K 10-Q · filed 2024-11-13 | $51.00K derived: sum of 2 quarters · filed 2024-11-13 | $58.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $53.00K 10-Q · filed 2024-08-19 | $60.00K 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |